Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and Sexual Health Choices
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- University of Georgia
- Study ID
- NCT07173816
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- HIV Pre-exposure Prophylaxis
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- EMPOWER — BEHAVIORALEMPOWER, a group-based 6 sessions telehealth behavioral intervention, will comprise sexual health goals and values elicitation, sexual health plan development, and motivational enhancement skills will be used to promote effective HIV prevention decision-making within the relationship context, incorporating the sexual values of each participant. This will allow each participant to develop a personalized, tailored sexual health plan that includes PrEP deliberation to enhance PrEP decision-making, uptake and persistence within a culturally congruent and empowering program that aims to reduce stigma around HIV and barriers to access.
Study Details
Pilot testing of EMPOWER, a group sexual health intervention, to increase uptake and persistence of PrEP
Key Dates
- Start date
- Aug 1, 2026
- Status verified
- Sep 2025
- Primary completion
- Mar 31, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Intervention ArmThis arm will receive the intervention first.
- Active Comparator: Waitlist ControlThis arm will receve the intervention after the wait period
Primary Outcome Measure
Feasibility of EMPOWER Intervention [ Time Frame: From enrollment to the end of data collection and analysis at 6 months ]
Central Contacts
- Mohammad Rifat Haider, Ph.D.803-477-4289
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Empowerment Resource Center | Atlanta | Georgia | 30303 | - |
Find similar trials in Atlanta, GA
By research site
Related Studies
- Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)Not Yet Recruiting · University of Georgia · Colbert, Georgia
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)PHASE3 · Recruiting · Merck Sharp & Dohme LLC · Birmingham, Alabama
- Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)PHASE3 · Recruiting · Gilead Sciences · Birmingham, Alabama
- Client-Centered Care Coordination for Black Men Who Have Sex With MenEnrolling By Invitation · University of Maryland, Baltimore · Washington D.C., District of Columbia